HIGHLIGHTS
- who: S. Weltings from the Haga Teaching Hospital, The Hague, The Netherlands have published the research: The BUSCOPAN study: a randomized-controlled non-inferiority trial of a continuous butylscopolamine infusion versus placebo in patients with a renal colic not responding to oral non-steroidal anti-inflammatory drugs, in the Journal: (JOURNAL)
- what: The aim was to assess whether placebo is non-inferior to continuous intravenous infusion with butylscopolamine in patients admitted for pain due to renal colic with regards to amount of opioid escape medication needed.
- how: The authors conducted a placebo-controlled . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.